The biggest regulatory differences between Malaysia, Singapore and Thailand: for Class B and higher medical devices, Conformity Assessment Body (CAB) conformity assessment must be completed before submission to MDA. Malaysia is governed by the Medical Device Act 737, with the Medical Device Authority (MDA) as the regulatory authority. Applications are submitted electronically via the MeDC@St portal, and technical dossiers adopt the ASEAN Common Submission Dossier Template (CSDT). Core rule: CAB conformity assessment first, then MDA registration review. CAB assessment is a mandatory prerequisite for registration and cannot be skipped. Many enterprises misunderstand the positioning of CAB, resulting in project delays. This open class at Beijing CMEF breaks down the registration process for Class C/D high-risk medical devices in Malaysia, key points of CAB assessment, timeline planning and common pitfalls.
Risk classification: 4 classes (Class A/B/C/D).
CAB assessment is mandatory for Class B and above. CAB Conformity Assessment: MDA-recognized CAB reviews the full CSDT dossier and issues a conformity assessment report. Submit registration application via the MeDC@St system with the CAB assessment conclusion attached. MDA conducts compliance review.
Approval and certificate issuance. The certificate is valid for 5 years, followed by import and distribution.
Note: Deficiency letters raised during the CAB phase will directly delay registration submission. The full CAB cycle must be included in project scheduling, rather than only counting the MDA review timeline.
A CAB is an MDA-recognized conformity assessment body responsible for auditing the quality management system and full CSDT technical dossier of the product.
Major bodies: SIRIM QAS, SGS Malaysia, BSI Malaysia, DQS, etc.
Lookup channel: Check the CAB directory on the MDA official portal portal.mda.gov.my.
Language: Technical documents in English. Labelling and IFU are available in Bahasa Malaysia or English. Paper IFU is mandatory for home-use medical devices; electronic IFU is acceptable for professional devices, provided version control and risk analysis are performed.
| Risk Class | Overall Reference Timeline | Remarks |
|---|---|---|
| Class B | 6–9 months | Sequential CAB + MDA review |
| Class C | 9–12 months | CAB scheduling heavily impacts the overall timeline |
| Class D | 12–18 months | High-risk implantable products are recommended to reserve time up to the upper limit |
Certificate validity: 5 years. Renewal is not a direct certificate replacement. CAB reassessment must be completed before expiry. It is recommended to initiate renewal projects 1 year in advance to avoid certificate lapse.
Post-market surveillance obligations: PMS & PMCF plans and reports, adverse event reporting.